Leukemia in press

Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study
comparing acalabrutinib with or without obinutuzumab versus obinutuzumab
plus chlorambucil in treatment-naïve chronic lymphocytic leukemia.

Sharman JP, Egyed M, Jurczak W, Skarbnik A, Pagel JM, Flinn IW, Kamdar M, Munir T, Walewska R, Corbett G, Fogliatto LM, Herishanu Y, Banerji V, Coutre S, Follows G, Walker P, Karlsson K, Ghia P, Janssens A, Cymbalista F, Woyach JA, Ferrant E, Wierda WG, Munugalavadla V, Yu T, Wang MH, Byrd JC